PeptiVA
CJC-1295 No DAC + Ipamorelin 10 mg (5+5) injection pen
Injection Pen

CJC-1295 No DAC + Ipamorelin

GHRH analogue + GH secretagogue blend

Pairs CJC-1295 (No DAC), a GHRH analogue, with Ipamorelin, a selective GH secretagogue — a gold-standard GH-stimulating combination for body composition support. Together they promote amplified, pulsatile GH release for recovery, body composition and sleep quality. Typical Course: A full course runs 12 weeks. It begins with a 2-week assessment phase at a lower dose (100mcg of each peptide, once daily before bed) so you can monitor sleep-quality changes, followed by a 10-week protocol at 100–300mcg of each peptide, dosed once or twice daily — typically morning and evening — for maximum GH pulse. Most customers notice initial effects around week 3, with results peaking around week 8. What to Expect: Improved sleep quality, faster recovery, leaner body composition and improved skin and hair quality. Key benefits include synergistic GH stimulation, twice-daily dosing flexibility, good tolerability and improved sleep quality. Considerations & Safety: This combination involves more frequent dosing, and water retention or carpal-tunnel-like tingling are possible; effects are generally less pronounced than exogenous GH. Common side effects include brief flushing (from Ipamorelin), water retention, headache and tingling in the extremities. Seek medical attention immediately if you experience significant swelling, signs of infection, severe headache, or chest pain.

Active Dosage

10 mg (5+5)

Purity

99%+

Select dosage
1
Total

900 AED

SequenceAvailable on request
Molecular FormulaAvailable on request
Molecular WeightAvailable on request
CAS Number863288-34-0 / 170851-70-4
FormReconstituted injection pen
Purity≥ 99%+

Related Compounds